In a study with 12 patients with various EARS2 gene mutations, all had similar MRI findings (Steenweg et al., 2012), suggesting that cranial MRI may be more accountable evidence than standard biochemical studies for the discrimination of ARS-associated diseases. The gene discussed is EARS2; the disease is Axenfeld-Rieger syndrome.